^
    Back
    Association details:
    Biomarker:FCER1G expression
    Cancer:Glioma
    Drug Class:Immunotherapy
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Res Sq
    Title:

    Prognostic and Predictive Value of FCER1G in Glioma Outcomes and Response to Immunotherapy

    Published date:
    11/04/2020
    Excerpt:
    At last, we predict the immunotherapeutic response in both high and low FCER1G expression subgroups....Assess expression of FCER1G is a promising method to discover patients that may benefit from immunotherapy.